Delivery Order SPE2DB22D2007-SPE2DB25FJ3CY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,894.37 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on August 25, 2025, with completion scheduled for August 26, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a $21,972.38 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of TALTZ 80 mg/mL autoinjectors. This firm fixed-price delivery order, which is expected to be completed by August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Auto-Injector with a ceiling value of $6,500.68 under firm fixed pricing. This non-competitive delivery order is scheduled for completion by August 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a prescription biologic medication used to treat inflammatory conditions, and the auto-injector formulation provides...
- The Defense Logistics Agency awarded a delivery order valued at $3,086.38 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on July 23, 2025, with an ultimate completion date of July 24, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant used primarily to treat...
- The Defense Logistics Agency awarded a $4,871.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on July 22, 2025, with completion scheduled for July 23, 2025. This non-set-aside competitive award will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication used to treat autoimmune inflammatory conditions, and the autoinjector formulation enables patient self-administration of...
- The Defense Logistics Agency awarded a $5,392.46 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack) pharmaceutical supplies. This non-set-aside, firm fixed price delivery order was executed on July 30, 2025, with an ultimate completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant medication used to treat autoimmune inflammatory...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of TALTZ 80 mg/ml auto-injector two-packs with a ceiling value of $8,391.13. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $3,320.62 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on August 7, 2025, with ultimate completion by August 8, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TALTZ is a biologic medication used to treat autoimmune conditions, and this procurement represents a routine...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,383.13 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Syringe on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant medication commonly used to treat inflammatory conditions...
- The Defense Logistics Agency awarded a delivery order valued at $4,871.55 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml syringes, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant used to treat inflammatory...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3CYDelivery Order
The Defense Logistics Agency awarded a $7,021.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML autoinjector on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication used to treat inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, representing part of the agency's ongoing pharmaceutical procurement to support military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies comprehensive pharmaceutical products and medical supplies to support Defense Health Agency and military healthcare programs worldwide through competitively awarded contracts with firm fixed pricing structures across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 7/18/25 |